Profit Or Loss [Abstract]

Zealand Pharma - Filing #1350008

Concept	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31
Profit or loss [abstract]
Profit (loss) [abstract]
Revenue	—	342,788,000 DKK	—	—	—	—	103,986,000 DKK	—	—	—
Cost of sales	—	10,036,000 DKK	—	—	—	—	- DKK	—	—	—
Gross profit	—	323,614,000 DKK	—	—	—	—	103,986,000 DKK	—	—	—
Other income	—	15,979,000 DKK	—	—	—	—	- DKK	—	—	—
Other expense, by function	—	11,000,000 DKK	—	—	—	—	57,587,000 DKK	—	—	—
Profit (loss) from operating activities	—	572,238,000 DKK	—	—	—	—	837,153,000 DKK	—	—	—
Finance income	—	54,115,000 DKK	—	—	—	—	133,270,000 DKK	—	—	—
Finance costs	—	190,742,000 DKK	—	—	—	—	268,158,000 DKK	—	—	—
Profit (loss) before tax	—	708,865,000 DKK	—	—	—	—	972,041,000 DKK	—	—	—
Tax expense (income)	—	5,126,000 DKK	—	—	—	—	6,431,000 DKK	—	—	—
Profit (loss) from continuing operations	—	703,739,000 DKK	—	—	—	—	965,610,000 DKK	—	—	—
Profit (loss) from discontinued operations	—	- DKK	—	—	—	—	236,525,000 DKK	—	—	—
Profit (loss)	- DKK	703,739,000 DKK	703,739,000 DKK	- DKK	- DKK	- DKK	1,202,135,000 DKK	- DKK	1,202,135,000 DKK	- DKK
Earnings per share [text block]	—	—	—	—	—	—	—	—	—	—
Earnings per share [abstract]
Earnings per share [line items]
Diluted earnings per share [abstract]
Diluted earnings (loss) per share from continuing operations	—	12.44	—	—	—	—	20.90	—	—	—
Diluted earnings (loss) per share from discontinued operations	—	-	—	—	—	—	5.12	—	—	—
Diluted earnings (loss) per share	—	12.44	—	—	—	—	26.02	—	—	—